Amyloid pathology is associated with semantic loss in patients with subjective cognitive decline
نویسندگان
چکیده
Background Evidence is emerging that subtle language decline an early indicator of Alzheimer’s disease (AD). This study assessed change in semantic and letter fluency individuals with subjective cognitive (SCD), examined whether trajectories differed between without amyloid-beta (Aβ)-pathology. Method Longitudinal data from 437 the memory clinic-based Amsterdam Dementia Cohort were included (Age 61±8 years, 184(42%) Female, follow-up time 5.3±3.7 years; Table 1). Participants classified as SCD at baseline, had available baseline Aβ-information least 1 on or fluency. Baseline Aβ-status was dichotomized positive/negative based local cut-offs for Aβ1-42 concentrations cerebrospinal fluid, visual inspection amyloid positron emission tomography-imaging (Florbetapir PiB). Two linear mixed models (LMM) used to investigate Models time*Aβ-status predictors interest, a random intercept participant, age, sex, education adjusted for. LMMs subsequently stratified Aβ-status. Result At groups did not differ (p = 0.313) 0.294). Over Aβ-positive changed more rapidly compared Aβ-negative (β -0.32,CI -0.49 – -0.14;p<.001). The group declined 0.35 words per year (CI -0.20;p<.001), while show 0.03;CI -0.12 0.06;p 0.496) (Figure On differently -0.38;CI -0.72 -0.04;p 0.028), extent progress 0.10;CI -0.21 0.41;p 0.533), improved 0.47 0.29 0.65;p<.001) 2). Conclusion Our results indicate decreased fluency, but remained stable In contrast, they over time, which might suggest learning effect. These findings presence Aβ-pathology characterized by loss, highlighting potential performance biomarker SCD.
منابع مشابه
Is Sudden Hearing Loss Associated with Atherosclerosis?
Introduction: Sudden sensorineural hearing-loss (SSNHL) patients constitute approximately 2–3% of referrals to ear, nose and throat (ENT) clinics. Several predisposing factors have been proposed for this condition; one of which is vascular disorders and perfusion compromise. In this research the atherosclerotic changes and their known risk factors are studied in SSNHL patients. Materials and ...
متن کاملIncreased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline.
BACKGROUND Alzheimer disease is characterized by cognitive decline, senile plaques of β-amyloid (Aβ) peptides, neurofibrillary tangles composed of hyperphosphorylated τ proteins and neuronal loss. Aβ and τ are useful markers in the cerebrospinal fluid (CSF). C-Jun N-terminal kinases (JNKs) are serine-threonine protein kinases activated by phosphorylation and involved in neuronal death. METHOD...
متن کاملthe past hospitalization and its association with suicide attempts and ideation in patients with mdd and comparison with bmd (depressed type) group
چکیده ندارد.
Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline
Individuals with Down syndrome (DS) are more likely to experience earlier onset of multiple facets of physiological aging. This includes brain atrophy, beta amyloid deposition, cognitive decline, and Alzheimer's disease-factors indicative of brain aging. Here, we employed a machine learning approach, using structural neuroimaging data to predict age (i.e., brain-predicted age) in people with DS...
متن کاملVascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline.
Sporadic, late-onset Alzheimer disease (AD) constitutes the most frequent cause of dementia in the elderly population. AD-related pathology is often accompanied by vascular changes. The predominant vascular lesions in AD are cerebral amyloid angiopathy (CAA) and arteriosclerosis/lipohyalinosis (AS/LH). The present study was carried out to examine the coincidence of these small vessel pathologie...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Alzheimers & Dementia
سال: 2023
ISSN: ['1552-5260', '1552-5279']
DOI: https://doi.org/10.1002/alz.063833